>> 全站文章索引 >> 第45页: Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes? - [Linda Franchini, David Rossini, Fanny Bongiorno, Chiara Spagnolo, Enrico Smeraldi and Raffaella Zanardi] Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity - [Ulrich W. Preuss, Michael Soyka, Miriam Bahlmann, Karin Wenzel, Stefanie Behrens, Sylvia de Jonge, Marc Krüger and Brigitta Bondy] Antidepressants: past, present and future - [Jerzy Vetulani and Irena Nalepa] Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine - [S. C. Cheetham, J. A. Viggers, N. A. Slater and D. J. Heal] Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil - [L. Ferraro, K. Fuxe, S. Tanganelli, M. Fernandez, F. A. Rambert and T. Antonelli] Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment - [N. Brunello, J. A. den Boer, L. L. Judd, S. Kasper, J. E. Kelsey, M. Lader, Y. Lecrubier, J. P. Lepine, R. B. Lydiard, J. Mendlewicz, et al.] P01.15 Neurocognitive changes in adjustment disorder with depressed mood: Use of paroxetine - [.] Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions - [T. A. Slotkin, F. J. Seidler and S. F. Ali] Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine - [éva Hajós-Korcsok, Sarah F. B. McTavish and Trevor Sharp] LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone - [Ian A. Pullar, Stephen L. Carney, Ellen M. Colvin, Virginia L. Lucaites, David L. Nelson and Susan Wedley] Do antidepressants affect motivation in conditioned place preference? - [Fazal Subhan, Paul N. Deslandes, David M. Pache and Robert D. E. Sewell] Treatment of depression and concomitant anxiety - [David Nutt] The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome - [Cameron R. Hernandez, Gwenn S. Smith, Patricia R. Houck, Bruce G. Pollock, Benoit Mulsant, Mary Amanda Dew and Charles F. Reynolds III] Serotonergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia - [Michael Maes, Robert Verkerk, Laure Delmeire, Ann Van Gastel, Fran van Hunsel and Simon Scharpé] Serotonin transporter inhibitors: synthesis and binding potency of 2′-methyl- and 3′-methyl-6-nitroquipazine - [John M. Gerdes, Steven C. DeFina, Paul A. Wilson and Scott E. Taylor] Salmon calcitonin potentiates the analgesia induced by antidepressants - [María Jesús Ormazábal, Carlos Goicoechea, Eva Sánchez and María Isabel Martín] Nicotine exposure during pregnancy is a factor which influences serotonin transporter density in the rat brain - [Katsumasa Muneoka, Tetsuo Ogawa, Kenji Kamei, Yuichi Mimura, Hitomi Kato and Morikuni Takigawa] Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures - [Carolyn S. Dewa, Jeffrey S. Hoch and Paula Goering] Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats - [Andrew Harkin, Thomas J. Connor, Jane Mulrooney, John P. Kelly and Brian E. Leonard] Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder - [Mats Humble, Susanne Bejerot, Peter B. F. Bergqvist and Finn Bengtsson] Asymmetric syntheses of trans-3,4-disubstituted 2-piperidinones and piperidines - [Lee Tai Liu, Pao-Chiung Hong, Hsiang-Ling Huang, Shyh-Fong Chen, Chia-Lin Jeff Wang and Yuh-Sheng Wen] Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? - [Denis Joseph Paul David, Bríd á. Nic Dhonnchadha, Pascale Jolliet, Martine Hasco?t and Michel Bourin] Modafinil does not affect serotonin efflux from rat frontal cortex synaptosomes: comparison with known serotonergic drugs - [Luca Ferraro, Sergio Tanganelli, Kjell Fuxe, Bertha Wonje Bebe, Maria Cristina Tomasini, Francis A. Rambert and Tiziana Antonelli] Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the wistar rat - [Eamond D. O] Sumatriptan, 5-HT1D receptors and obsessive-compulsive disorder - [Lorrin M. Koran, Stefano Pallanti and Leonardo Quercioli] Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice - [Florence Clenet, Anouk De Vos and Michel Bourin] Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors - [M. H. Nelson, A. K. Birnbaum and R. P. Remmel] Methylenedioxymethamphetamine-induced suppression of interleukin-1β and tumour necrosis factor-α is not mediated by serotonin - [Thomas J. Connor, Michael C. Dennedy, Andrew Harkin and John P. Kelly] Récepteurs 5-HT1B de la sérotonine et effets antidépresseurs des inhibiteurs de recapture sélectifs de la sérotonine5-HT1B receptors mediate the antidepressant effects of selective serotonin reuptake inhibitors. - [Alain M. Gardier, Anne-Cécile Trillat, Isabelle Malagié, Denis David, Martine Hasco?t, Marie-Claude Colombel, Pascale Jolliet, Christian Jacquot, René Hen and Michel Bourin] Retinopathy associated with high-dose interferon alfa-2b therapy - [Charles Hejny, Paul Sternberg, David H. Lawson, Kristen Greiner and Thomas M. Aaberg] An open study of paroxetine in hypochondriasis - [Desiree B. Oosterbaan, Anton J. L. M. Van Balkom, Christine A. Van Boeijen, Tim GJ De Meij and Richard van Dyck] Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism? - [Thomas I. F. H. Cremers, Loes J. Wiersma, Fokko J. Bosker, Johan A. den Boer, Ben H. C. Westerink and H?kan V. Wikstr?m] Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment - [M. Bixo, P. Allard, T. B?ckstr?m, T. Mj?rndal, S. Nyberg, O. Spigset and I. Sundstr?m-Poromaa] Brain metabolic changes associated with symptom factor improvement in major depressive disorder - [Arthur L. Brody, Sanjaya Saxena, Mark A. Mandelkern, Lynn A. Fairbanks, Matthew L. Ho and Lewis R. Baxter] Ring expansion: formal total synthesis of (?)-paroxetine - [Janine Cossy, Olivier Mirguet, Domingo Gomez Pardo and Jean-Roger Desmurs] Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine - [Michael J. Owens, David L. Knight and Charles B. Nemeroff] Decreased platelet [3H]paroxetine binding sites in suicide attempters - [Antonella Armani, Gino Giannaccini, Elena Di Nasso, Antonio Lucacchini and Giovanni B. Cassano] Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos - [Kimberly W. Raines, Frederic J. Seidler and T. A. Slotkin] High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum - [G. Tournel, N. Houdret, V. Hédouin, M. Deveaux, D. Gosset and M. Lhermitte] Fetal and adolescent nicotine administration: effects on CNS serotonergic systems - [Z. Xu, F. J. Seidler, S. F. Ali, W. Slikker and T. A. Slotkin] Tryptophan hydroxylase gene associated with paroxetine antidepressant activity - [Alessandro Serretti, Raffaella Zanardi, Cristina Cusin, David Rossini, Cristina Lorenzi and Enrico Smeraldi] A short formal synthesis of paroxetine. Diastereoselective cuprate addition to a chiral racemic olefinic amido ester - [Janine Cossy, Olivier Mirguet, Domingo Gomez Pardo and Jean-Roger Desmurs] Status of minor depression or dysthymia in primary care following a randomized controlled treatment - [Thomas E. Oxman, James E. Barrett, Anjana Sengupta, Wayne Katon, John W. Williams, Ellen Frank and Mark Hegel] Endogenous concentrations of DHEA and DHEA-S Decrease with remission of depression in older adults - [Tanya J. Fabian, Mary Amanda Dew, Bruce G. Pollock, Charles F. Reynolds, Benoit H. Mulsant, Meryl A. Butters, Michelle D. Zmuda, Ana M. Linares, Mario Trottini and Patricia D. Kroboth] No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors - [Alessandro Serretti, Raffaella Zanardi, Cristina Cusin, David Rossini, Roberta Lilli, Cristina Lorenzi, Enrico Lattuada and Enrico Smeraldi] In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT1B/1D/2 receptor antagonist properties - [Ian A. Pullar, John R. Boot, Stephen L. Carney, Marlene L. Cohen, Ellen M. Colvin, Richard G. Conway, Clare H. L. Hardy, Virginia L. Lucaites, David L. Nelson, Kathryn W. Schenck, et al.] Ontogeny of drug-metabolizing enzymes and its influence on the pathogenesis of adverse drug reactions in children - [J. Steven Leeder] Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor, in rat brain: an autoradiographic study with α-[14C]methyl--tryptophan - [Fumitaka Yamane, Hidehiko Okazawa, Pierre Blier and Mirko Diksic] Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons - [Steven T. Szabo and Pierre Blier] Effects of long-term lithium treatment on monoaminergic functions in major depression - [Aram El Khoury, Lars Johnson, Anna ?berg-Wistedt and Rigmor Stain-Malmgren] A survey of prescribing practices in the treatment of depression - [Timothy Petersen, Christina Dording, Nicole B. Neault, Rebecca Kornbluh, Jonathan E. Alpert, Andrew A. Nierenberg, Jerrold F. Rosenbaum and Maurizio Fava] Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebo-controlled, multi-dose study in healthy subjects - [Isabelle Loubinoux, Jérémie Pariente, Olivier Rascol, Pierre Celsis and Fran?ois Chollet] A Single Dose of the Serotonin Neurotransmission Agonist Paroxetine Enhances Motor Output: Double-Blind, Placebo-Controlled, fMRI Study in Healthy Subjects - [Isabelle Loubinoux, Jérémie Pariente, Kader Boulanouar, Christophe Carel, Claude Manelfe, Olivier Rascol, Pierre Celsis and Fran?ois Chollet] The effect of changes in depression on health related quality of life (HRQoL) in HIV infection - [Andrew J. Elliott, Joan Russo and Peter P. Roy-Byrne] Predictors of nonresponse to treatment in primary care patients with dysthymia - [Wayne Katon, Joan Russo, Ellen Frank, James Barrett, John W. Williams, Thomas Oxman, Mark Sullivan and John Cornell] Correlates of remission in primary care patients treated for minor depression - [Ellen Frank, Paola Rucci, Wayne Katon, James Barrett, John W. Williams, Thomas Oxman, Mark Sullivan and John Cornell] Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes - [P. Molander, A. Thomassen, L. Kristoffersen, T. Greibrokk and E. Lundanes] The effects of antidepressant drug treatments on activator protein-1 binding activity in the rat brain - [Tatsuji Tamura, Shigeru Morinobu, Yasumasa Okamoto, Ariyuki Kagaya and Shigeto Yamawaki] Selective serotonin reuptake inhibitor discontinuation syndrome in children: Six case reports - [Rasim Somer Diler and Ayse Avci] Impaired release of β-endorphin in response to serotonin in a rat model of depression - [A. Zangen, R. Nakash, I. Roth-Deri, D. H. Overstreet and G. Yadid] The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT1B receptor knockout mice - [Lotte De Groote, Berend Olivier and Herman G. M. Westenberg] Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake: A pharmacological characterization of diverse classes of antidepressant agents - [Mauricette Brocco, Anne Dekeyne, Sylvie Veiga, Sylvie Girardon and Mark J. Millan] Effect of SB-243213, a selective 5-HT2C receptor antagonist, on the rat sleep profile: A comparison to paroxetine - [M. I. Smith, D. C. Piper, M. S. Duxon and N. Upton] A Pilot Trial of Paroxetine for the Treatment of Hot Flashes and Associated Symptoms in Women with Breast Cancer - [Michael A. Weitzner, Joanne Moncello, Paul B. Jacobsen and Susan Minton] Intent-to-treat analysis for clinical trials: use of data collected after termination of treatment protocol - [Sati Mazumdar, Patricia R. Houck, Kenneth S. Liu, Benoit H. Mulsant, Bruce G. Pol1ock, Mary Amanda Dew and Charles F. Reynolds III] Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling - [J. Landgrebe, G. Welzl, T. Metz, M. M. van Gaalen, H. Ropers, W. Wurst and F. Holsboer] EEG correlates of acute and chronic paroxetine treatment in depression - [Verner Knott, Colleen Mahoney, Sidney Kennedy and Kenneth Evans] Course and rate of antidepressant response in the very old - [Ariel G. Gildengers, Patricia R. Houck, Benoit H. Mulsant, Bruce G. Pollock, Sati Mazumdar, Mark D. Miller, Mary Amanda Dew, Ellen Frank, David J. Kupfer and Charles F. Reynolds III] How well do antidepressants work in older people? A systematic review of Number Needed to Treat - [.] Effect of treatment of panic disorder in patients with frequent ICD discharges: a pilot study - [P. M. J. C. Kuijpers, A. Honig and H. J. J. Wellens] Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT1B receptor knock-out mice - [Isabelle Malagié, Denis J. David, Pascale Jolliet, René Hen, Michel Bourin and Alain M. Gardier] Differential effects of chronic antidepressant treatments on μ- and δ-opioid receptors in rat brain - [Catherine Vilpoux, Céline Carpentier, Isabelle Leroux-Nicollet, Laurent Naudon and Jean Costentin] Penetrating the blind in a study of an SSRI - [Melissa P. Piasecki, David O. Antonuccio, Gerri M. Steinagel, Barbara S. Kohlenberg and Karen Kapadar] Serotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder - [E. Hernández, S. Lastra, M. Urbina, I. Carreira and L. Lima] Acute effects of amperozide and paroxetine on social cohesion in male conspecifics - [David J. Rademacher, Anthony P. Anderson and Rhea E. Steinpreis] Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography - [L. Labat, M. Deveaux, P. Dallet and J. P. Dubost] Reduced (±)-3,4-methylenedioxymethamphetamine (“Ecstasy”) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro - [Yamini Ramamoorthy, Ai-ming Yu, Nina Suh, Robert L. Haining, Rachel F. Tyndale and Edward M. Sellers] Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative - [Feng C. Zhou, Klaus-Peter Lesch and Dennis L. Murphy] Aging alters in a region-specific manner serotonin transporter sites and 5-HT1A receptor-G protein interactions in hamster brain - [Marilyn J. Duncan and Julie G. Hensler] Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures - [Ashwin A. Patkar, Charles C. Thornton, Wade H. Berrettini, Edward Gottheil, Stephen P. Weinstein and Kevin P. Hill] Clinical implications of pharmacogenetics of antidepressants - [Koichi Otani, Kazuo Mihara, Norio Yasui-Furukori, Akihito Suzuki, Tsuyoshi Kondo and Sunao Kaneko] A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression - [S. Kasper and J. P. Olié] Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study - [Eric Michael Kaplan] 7,7,8,8-Tetracyanoquinodimethane as a new derivatization reagent for high-performance liquid chromatography and thin-layer chromatography: rapid screening of plasma for some antidepressants - [Aysel Oztunc, Armagan Onal and S?d?ka Erturk] Carnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats - [David Pubill, Ester Verdaguer, Francesc X. Sureda, Antoni Camins, Mercè Pallàs, Jordi Camarasa and Elena Escubedo] A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder - [Paola Rocca, Valeria Fonzo, Luigi Ravizza, Giuseppe Rocca, Monica Scotta, Enrico Zanalda and Filippo Bogetto] Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT2A receptors in Brodmann areas and brain hemispheres - [Pilar Rosel, Belén Arranz, Mikel Urretavizcaya, Miguel Oros, Luis San, Julio Vallejo and Miguel Angel Navarro] An open-label dosing study of paroxetine in depressed children and adolescents - [Robert L. Findling, Carolyn Myers, Mary Ann O] Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures - [Vikram K. Yeragani, Vanessa Pesce, Anusha Jayaraman and Steven Roose] Inhibition of vesicular uptake of monoamines by hyperforin - [Netta Roz, Yehuda Mazur, Amiram Hirshfeld and Moshe Rehavi] Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression - [Paola Rocca, Concetta De Leo, Carola Eva, Livio Marchiaro, Anna Maria Milani, Rita Musso, Luigi Ravizza, Enrico Zanalda and Filippo Bogetto] Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine - [D. Gervasoni, E. Panconi, V. Henninot, R. Boissard, B. Barbagli, P. Fort and P. H. Luppi] A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes - [Paola Rocca, Livio Marchiaro, Roberta Rasetti, Elisa Rivoira and Filippo Bogetto] Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission - [Paul N Deslandes, David M Pache, Paul Buckland and Robert D.E Sewell] Enzymatic resolution of (±)-trans-4-(4′-fluorophenyl)-6-oxo-piperidin-3-ethyl carboxylate, an intermediate in the synthesis of (?)-Paroxetine - [Jose M. Palomo, Gloria Fernández-Lorente, Cesar Mateo, Roberto Fernández-Lafuente and José M. Guisan] A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder - [Jeffrey S. McCombs, Lizheng Shi, Glen L. Stimmel and Thomas W. Croghan] Improved sample preparation for the quantitative analysis of paroxetine in human plasma by stable isotope dilution negative ion chemical ionisation gas chromatography–mass spectrometry - [Hans J?rg Leis, Werner Windischhofer and Günter Fauler] Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine - [Jun Fujishiro, Taiichiro Imanishi, Kaname Onozawa and Masaki Tsushima] High-performance liquid chromatography–mass spectrometry method for the determination of paroxetine in human plasma - [Zhimeng Zhu and Len Neirinck] The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression - [Dorotea Mück-eler, Nela Pivac, Marina agud, Miro Jakovljevi and Alma Mihaljevi-Pele] 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 [45] 46 47 48 49 50